WELLBUTRIN - 0187-0730-30 - (bupropion hydrochloride)

Alphabetical Index


Drug Information of WELLBUTRIN

Product NDC: 0187-0730
Proprietary Name: WELLBUTRIN
Non Proprietary Name: bupropion hydrochloride
Active Ingredient(s): 150    mg/1 & nbsp;   bupropion hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of WELLBUTRIN

Product NDC: 0187-0730
Labeler Name: Valeant Pharmaceuticals North America LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021515
Marketing Category: NDA
Start Marketing Date: 20091223

Package Information of WELLBUTRIN

Package NDC: 0187-0730-30
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-30)

NDC Information of WELLBUTRIN

NDC Code 0187-0730-30
Proprietary Name WELLBUTRIN
Package Description 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-30)
Product NDC 0187-0730
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name bupropion hydrochloride
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20091223
Marketing Category Name NDA
Labeler Name Valeant Pharmaceuticals North America LLC
Substance Name BUPROPION HYDROCHLORIDE
Strength Number 150
Strength Unit mg/1
Pharmaceutical Classes Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]

Complete Information of WELLBUTRIN


General Information